Display options
Cite
Godoy G, Gakis G, Smith CL, et al. Effects of Androgen and Estrogen Receptor Signaling Pathways on Bladder Cancer Initiation and Progression. Bladder Cancer. 2016;2(2):127-137doi: 10.3233/BLC-160052.
Godoy, G., Gakis, G., Smith, C. L., & Fahmy, O. (2016). Effects of Androgen and Estrogen Receptor Signaling Pathways on Bladder Cancer Initiation and Progression. Bladder cancer (Amsterdam, Netherlands), 2(2), 127-137. https://doi.org/10.3233/BLC-160052
Godoy, Guilherme, et al. "Effects of Androgen and Estrogen Receptor Signaling Pathways on Bladder Cancer Initiation and Progression." Bladder cancer (Amsterdam, Netherlands) vol. 2,2 (2016): 127-137. doi: https://doi.org/10.3233/BLC-160052
Godoy G, Gakis G, Smith CL, Fahmy O. Effects of Androgen and Estrogen Receptor Signaling Pathways on Bladder Cancer Initiation and Progression. Bladder Cancer. 2016 Apr 27;2(2):127-137. doi: 10.3233/BLC-160052. PMID: 27376135; PMCID: PMC4927898.
Copy Download .nbib Format: NLM
Share it on

Bladder Cancer. 2016 Apr 27;2(2):127-137. doi: 10.3233/BLC-160052.

Effects of Androgen and Estrogen Receptor Signaling Pathways on Bladder Cancer Initiation and Progression.

Bladder cancer (Amsterdam, Netherlands)

Guilherme Godoy, Georgios Gakis, Carolyn L Smith, Omar Fahmy

Affiliations

  1. Scott Department of Urology, Baylor College of Medicine , Houston, TX, USA.
  2. Department of Urology, Eberhard-Karls University , Tuebingen, Germany.
  3. Scott Department of Urology, Baylor College of Medicine, Houston, TX, USA; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA.

PMID: 27376135 PMCID: PMC4927898 DOI: 10.3233/BLC-160052

Abstract

Epidemiologic studies have long demonstrated clear differences in incidence and progression of bladder cancer between genders suggesting that the mechanisms of development and progression in these tumors have a strong association with steroid hormonal pathways. Such observations led to preclinical studies investigating the role of androgen and estrogen receptors, as well as their cognate hormones in bladder cancer initiation and progression. Using various

Keywords: Androgens; androgen; androgen antagonists; carcinogenesis; disease progression; estrogen; estrogen receptor modulators; estrogens; receptor; receptors; urinary bladder neoplasms

References

  1. Transl Oncol. 2013 Jun 01;6(3):244-55 - PubMed
  2. J Urol. 2009 Nov;182(5):2195-203 - PubMed
  3. Carcinogenesis. 2014 Mar;35(3):651-61 - PubMed
  4. BJU Int. 2012 Jun;109(11):1716-26 - PubMed
  5. Int Urol Nephrol. 2015 Jan;47(1):81-5 - PubMed
  6. Oncotarget. 2014 Dec 30;5(24):12665-74 - PubMed
  7. Appl Immunohistochem Mol Morphol. 2009 Oct;17(5):393-402 - PubMed
  8. Eur Urol. 2013 Feb;63(2):234-41 - PubMed
  9. Arch Pathol Lab Med. 2005 Feb;129(2):194-9 - PubMed
  10. Eur Urol. 2014 Jan;65(1):69-76 - PubMed
  11. Am J Cancer Res. 2015 Feb 15;5(3):1146-57 - PubMed
  12. Eur Urol. 2014 Apr;65(4):778-92 - PubMed
  13. Urol Res. 1975 Aug 8;3(2):73-9 - PubMed
  14. Eur Urol. 2009 Aug;56(2):247-56 - PubMed
  15. Am J Clin Pathol. 2014 Aug;142(2):173-83 - PubMed
  16. Anticancer Res. 2001 Jan-Feb;21(1B):711-5 - PubMed
  17. Gend Med. 2012 Dec;9(6):481-9 - PubMed
  18. Urology. 2004 Aug;64(2):383-8 - PubMed
  19. BJU Int. 2010 Aug;106(3):357-61 - PubMed
  20. BMC Urol. 2008 Apr 23;8:7 - PubMed
  21. Eur Urol. 2013 Oct;64(4):639-53 - PubMed
  22. Oncotarget. 2014 Sep 15;5(17 ):7917-35 - PubMed
  23. World J Urol. 2012 Dec;30(6):861-7 - PubMed
  24. BJU Int. 2010 Feb;105(3):300-8 - PubMed
  25. World J Urol. 2013 Oct;31(5):1029-36 - PubMed
  26. Oncol Rep. 2013 Jul;30(1):131-8 - PubMed
  27. Nature. 2014 Mar 20;507(7492):315-22 - PubMed
  28. Urology. 2000 Jun;55(6):876-80 - PubMed
  29. Urol J. 2014 Nov 30;11(6):1968-73 - PubMed
  30. J Natl Cancer Inst. 2001 Apr 4;93(7):538-45 - PubMed
  31. Yonsei Med J. 2014 Sep;55(5):1214-21 - PubMed
  32. Cancer Res. 1999 Jul 15;59(14):3512-7 - PubMed
  33. J Urol. 2013 Apr;189(4):1470-4 - PubMed
  34. J Natl Cancer Inst. 1990 Oct 17;82(20):1636-40 - PubMed
  35. Am J Pathol. 2013 May;182(5):1811-20 - PubMed
  36. Endocr Relat Cancer. 2011 Jul 04;18(4):451-64 - PubMed
  37. Urol Oncol. 2011 Jan-Feb;29(1):43-51 - PubMed
  38. Endocr Relat Cancer. 2013 May 20;20(3):293-304 - PubMed
  39. Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):3110-5 - PubMed
  40. Clin Genitourin Cancer. 2015 Oct;13(5):476-84 - PubMed
  41. J Natl Cancer Inst. 2007 Apr 4;99(7):558-68 - PubMed
  42. Br J Urol. 1996 Jan;77(1):76-85 - PubMed
  43. Urol Oncol. 1997 Sep-Dec;3(5-6):141-7 - PubMed
  44. Endocr Rev. 2007 Dec;28(7):778-808 - PubMed
  45. CA Cancer J Clin. 2015 Mar;65(2):87-108 - PubMed
  46. Br J Cancer. 2013 Apr 16;108(7):1470-9 - PubMed
  47. Mol Cancer Ther. 2015 Nov;14 (11):2586-94 - PubMed
  48. Cancer Res. 1990 May 1;50(9):2848-52 - PubMed
  49. Carcinogenesis. 1999 Oct;20(10):1963-9 - PubMed
  50. Int J Cancer. 2008 Jun 1;122(11):2554-61 - PubMed
  51. Eur Urol. 2008 May;53(5):992-1001 - PubMed
  52. J Pathol. 1998 Oct;186(2):165-8 - PubMed
  53. Int J Urol. 2010 Sep;17(9):801-9 - PubMed
  54. Urology. 2010 Apr;75(4):820-7 - PubMed
  55. Urology. 2007 Jun;69(6):1221-6 - PubMed
  56. BJU Int. 2011 Jul;108(1):24-30 - PubMed
  57. Urology. 1985 Feb;25(2):161-3 - PubMed
  58. Cancer. 2006 Jun 15;106(12):2610-6 - PubMed
  59. Nat Clin Pract Urol. 2007 Apr;4(4):205-17 - PubMed
  60. Mol Carcinog. 2014 Apr;53(4):314-24 - PubMed
  61. Eur Urol. 2001 Aug;40(2):144-50 - PubMed
  62. Endocr Relat Cancer. 2008 Mar;15(1):351-64 - PubMed
  63. Mol Carcinog. 2011 Dec;50(12):931-44 - PubMed
  64. Endocr Relat Cancer. 2009 Mar;16(1):123-37 - PubMed
  65. J Urol. 1995 Aug;154(2 Pt 1):601-5 - PubMed
  66. Mol Carcinog. 2013 Feb;52(2):94-102 - PubMed
  67. Cancer Cell. 2014 Feb 10;25(2):152-65 - PubMed
  68. Gynecol Obstet Invest. 1992;34(2):105-10 - PubMed
  69. CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30 - PubMed
  70. Histopathology. 1997 Jun;30(6):556-62 - PubMed
  71. J Urol. 2001 Jan;165(1):47-50; discussion 50 - PubMed
  72. Eur Urol. 2009 Dec;56(6):1093-5 - PubMed
  73. J Clin Pathol. 2013 Sep;66(9):779-86 - PubMed
  74. Horm Cancer. 2013 Feb;4(1):24-35 - PubMed
  75. J Urol. 2001 May;165(5):1631 - PubMed
  76. Int J Clin Exp Pathol. 2015 May 01;8(5):4427-43 - PubMed
  77. BJU Int. 2012 Nov;110(9):1301-9 - PubMed

Publication Types

Grant support